| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
CREST, Japan Science and Technology Corporation and Genome Science Laboratory, RIKEN Tsukuba Institute, Ibaraki 305-0074, Japan; Genome Exploration Research Group, RIKEN Genomic Sciences Center, Yokohama 230-0045, Japan [M. T., Y. F., S. K., Y. O., J. K., K. S., M. I., M. M., Y. H.]; Cooperative Graduate School of Medicine, University of Tsukuba, Ibaraki 305-0006, Japan [S. K., Y. H.]; and Department of Molecular and Cellular Biology, Roswell Park Cancer Institute, Buffalo, New York 14263 [W. A. H.]
DNA methylation is the only known mechanism for an epigenetic genomic DNA modification that is capable of altering gene expression. A recent study reveals that the pattern of CpG island methylation is largely characteristic of tumor type, suggesting that distinct sets of genes are inactivated by methylation during development of each tumor type. We compared previously the methylation status between normal liver and liver tumors in SV40 T/t antigen transgenic mice (MT-D2 mice) using Restriction Landmark Genomic Scanning for Methylation (RLGS-M) and identified several loci/spots that appeared to be methylated frequently in liver tumors. One of these spots, B236, identified a locus on chromosome 12 (D12Ncvs7) syntenic with human 14q12q21 that is frequently lost in certain human cancers. Shotgun sequencing of a bacterial artificial chromosome clone containing this spot/locus was performed to identify genes within this region. The Genescan program predicted an open reading frame of a novel, intron-less gene adjacent to the B236 spot that encodes a putative 493-amino acid protein containing the SNAG repressor motif in the NH2-terminal region and five C2H2-type zinc finger motifs in the COOH-terminal half. This putative gene, methylated in liver tumor (mlt 1), is a novel member of the SNAG transcriptional repressor family with 43% amino acid identity to insulinoma-associated protein 1. An open reading frame encoding a protein quite similar to mouse mlt 1 (56% amino acid identity) was located in the syntenic region of the human genome, indicating that mlt 1 is evolutionarily conserved in human. Northern blot analysis revealed that mlt 1 is normally expressed in brain, spleen, stomach, and liver. However, mlt 1 expression was silenced in the liver tumors of MT-D2 mice. The putative promoter region of mlt 1 is unmethylated in normal tissues but methylated in all liver tumors from 11 MT-D2 mice. We also found that mlt 1 was methylated and not expressed in N18TG-2 cells, a mouse neuroblastoma cell line. Treatment of N18TG-2 cells with a demethylating agent, 5-aza-deoxycytidine, resulted in an expression of mlt 1, indicating that the repression of mlt 1 is attributable to methylation. Thus, mlt 1 is a novel target gene that is silenced by methylation during liver tumorigenesis initiated by SV40 T antigen.
This article has been cited by other articles:
![]() |
M. Tateno, H. Sadakata, M. Tanaka, S. Itohara, R.-M. Shin, M. Miura, M. Masuda, T. Aosaki, M. Urushitani, H. Misawa, et al. Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model Hum. Mol. Genet., October 1, 2004; 13(19): 2183 - 2196. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yu, R. F. Pretot, T. R. Burglin, and P. W. Sternberg Distinct roles of transcription factors EGL-46 and DAF-19 in specifying the functionality of a polycystin-expressing sensory neuron necessary for C. elegans male vulva location behavior Development, November 1, 2003; 130(21): 5217 - 5227. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Uhlmann-Schiffler, S. Seinsoth, and H. Stahl Preformed hexamers of SV40 T antigen are active in RNA and origin-DNA unwinding Nucleic Acids Res., July 15, 2002; 30(14): 3192 - 3201. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Breslin, M. Zhu, A. L. Notkins, and M. S. Lan Neuroendocrine differentiation factor, IA-1, is a transcriptional repressor and contains a specific DNA-binding domain: identification of consensus IA-1 binding sequence Nucleic Acids Res., February 15, 2002; 30(4): 1038 - 1045. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |